- Investor's Business Daily•yesterday
Dow leader Merck swiped share from rival Bristol-Myers as Roche remained flat, according to a health tracker.
- Zacks•2 days ago
Bristol-Myers Squibb Company (BMY) and CytomX Therapeutics, Inc. (CTMX), announced an expansion of their 2014 strategic collaboration to discover novel therapies.
- Investopedia•3 days ago
Heat Biologics’ lung-cancer drug combo reported promising results in a Phase 2 trial.
BMY : Summary for Bristol-Myers Squibb Company Co - Yahoo Finance
Bristol-Myers Squibb Company (BMY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||55.68 - 56.53|
|52 Week Range||46.01 - 77.12|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||21.05|
|Dividend & Yield||1.56 (2.80%)|
|1y Target Est||N/A|